BRPI0620054A8 - extrato obtenível por extração de phaseolus sp. com misturas de etanol e água, processo para a preparação deste, uso e composições dos mesmos - Google Patents

extrato obtenível por extração de phaseolus sp. com misturas de etanol e água, processo para a preparação deste, uso e composições dos mesmos

Info

Publication number
BRPI0620054A8
BRPI0620054A8 BRPI0620054A BRPI0620054A BRPI0620054A8 BR PI0620054 A8 BRPI0620054 A8 BR PI0620054A8 BR PI0620054 A BRPI0620054 A BR PI0620054A BR PI0620054 A BRPI0620054 A BR PI0620054A BR PI0620054 A8 BRPI0620054 A8 BR PI0620054A8
Authority
BR
Brazil
Prior art keywords
phaseolus
ethanol
mixtures
preparation
water
Prior art date
Application number
BRPI0620054A
Other languages
English (en)
Inventor
Gardi Andrea
Ponzone Cesare
Berlanda Davide
Bombardelli Ezio
Donzelli Fabio
Bertani Marco
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37888415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0620054(A8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Indena Spa filed Critical Indena Spa
Publication of BRPI0620054A2 publication Critical patent/BRPI0620054A2/pt
Publication of BRPI0620054A8 publication Critical patent/BRPI0620054A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Peptides Or Proteins (AREA)

Abstract

extrato obtenível por extração de phaseolus sp. com misturas de etanol e água, processo para a preparação deste, uso e composições dos mesmos. a presente invenção refere-se a extratos obteníveis por extração de phaseolus sp. com misturas de etanol e água, distinguidos por um teor de inibidores de <244>-amiiase entre 1.000 e 1.600 usp/mg (título por hplc entre 6 e 14% em peso) e um teor de fitoemaglutininas entre 8.000 e 30.000 hau/g, e um processo para sua preparação.
BRPI0620054A 2005-12-22 2006-12-13 extrato obtenível por extração de phaseolus sp. com misturas de etanol e água, processo para a preparação deste, uso e composições dos mesmos BRPI0620054A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT002450A ITMI20052450A1 (it) 2005-12-22 2005-12-22 Estratti di phaseolus vulgaris loro uso e formulazioni che li contengono
ITMI2005A002450 2005-12-22
PCT/EP2006/012012 WO2007071334A2 (en) 2005-12-22 2006-12-13 Ethanol-precipitated phaseolus vulgaris extracts, their use and formulations

Publications (2)

Publication Number Publication Date
BRPI0620054A2 BRPI0620054A2 (pt) 2011-11-01
BRPI0620054A8 true BRPI0620054A8 (pt) 2018-12-26

Family

ID=37888415

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0620054A BRPI0620054A8 (pt) 2005-12-22 2006-12-13 extrato obtenível por extração de phaseolus sp. com misturas de etanol e água, processo para a preparação deste, uso e composições dos mesmos

Country Status (17)

Country Link
US (2) US20090169657A1 (pt)
EP (1) EP1962877B1 (pt)
JP (1) JP5452931B2 (pt)
KR (1) KR101449763B1 (pt)
CN (1) CN101340923B (pt)
AU (1) AU2006328983B2 (pt)
BR (1) BRPI0620054A8 (pt)
CA (1) CA2634345C (pt)
DK (1) DK1962877T3 (pt)
ES (1) ES2813929T3 (pt)
IL (1) IL192292A (pt)
IT (1) ITMI20052450A1 (pt)
NO (1) NO346419B1 (pt)
PT (1) PT1962877T (pt)
RU (1) RU2426552C2 (pt)
SI (1) SI1962877T1 (pt)
WO (1) WO2007071334A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE431155T1 (de) 2007-03-07 2009-05-15 Indena Spa Formulierungen mit extrakten aus cynara scolymus und phaseolus vulgaris zur behandlung von adipositas
CN101555275B (zh) * 2009-05-08 2011-09-28 广东省食品工业研究所 一种利用生物酶法制备α-淀粉酶抑制剂的方法
KR20110138001A (ko) * 2010-06-18 2011-12-26 (주)아모레퍼시픽 유색콩 추출물을 함유하는 조성물
ITMI20121727A1 (it) * 2012-10-12 2014-04-13 Indena Spa Formulazioni per il trattamento e la prevenzione dell'obesita'
TW201427674A (zh) * 2013-01-15 2014-07-16 ji-min Song 花豆種子萃取物及其製備方法與用途
US9290752B2 (en) 2013-03-13 2016-03-22 Sunny Delight Beverages Co. Process for enhancing the amylase inhibitory efficacy from phaseolus vulgaris extracts
CA2974052A1 (en) * 2015-01-14 2016-07-21 Akop Surikovych KUTSANYAN Method for producing a complex of biologically active substances exhibiting hypoglycemic activity
CN116270793A (zh) * 2023-02-07 2023-06-23 湖南朗林生物资源股份有限公司 一种白芸豆提取物的制备方法及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2628757A1 (de) * 1976-06-26 1977-12-29 Guenter Dr Woeber Amylase inhibitor
JPH06116197A (ja) 1992-09-07 1994-04-26 Max Fuakutaa Kk 新規ラジカルスカベンジャー
GB9921229D0 (en) * 1999-09-08 1999-11-10 Med Eq As Compositions
US6797287B2 (en) * 2001-09-25 2004-09-28 Pharmachem Laboratories, Inc. Phaseolamin compositions and methods for using the same
MXPA05000092A (es) * 2002-06-28 2005-09-30 Pharmachem Lab Inc Inhibidores de amilasa purificado y proceso novedoso para obtener el mismo.
US20040131749A1 (en) * 2002-08-29 2004-07-08 Archer-Daniels-Midland Company Phytochemicals from edible bean process streams
ITMI20040619A1 (it) * 2004-03-30 2004-06-30 Consiglio Nazionale Ricerche Estratto purificato di inibitore dell'alfa-amilasi da fagioli essenzialmente privi di fitoemoagglutinina procedimento di estrazione e composizioni che lo contengono
ATE431155T1 (de) * 2007-03-07 2009-05-15 Indena Spa Formulierungen mit extrakten aus cynara scolymus und phaseolus vulgaris zur behandlung von adipositas
US7553502B2 (en) * 2007-03-07 2009-06-30 Indena S.P.A. Formulations of alpha-amylase inhibitors with alpha-glucosidase inhibitors useful in the treatment of diabetes and obesity

Also Published As

Publication number Publication date
ES2813929T3 (es) 2021-03-25
ITMI20052450A1 (it) 2007-06-23
KR101449763B1 (ko) 2014-10-13
RU2008124974A (ru) 2009-12-27
KR20080080127A (ko) 2008-09-02
BRPI0620054A2 (pt) 2011-11-01
EP1962877B1 (en) 2020-07-22
NO20082729L (no) 2008-07-08
CA2634345A1 (en) 2007-06-28
EP1962877A2 (en) 2008-09-03
AU2006328983B2 (en) 2012-06-28
US20090169657A1 (en) 2009-07-02
DK1962877T3 (da) 2020-08-31
WO2007071334A2 (en) 2007-06-28
CN101340923A (zh) 2009-01-07
US20170333508A1 (en) 2017-11-23
WO2007071334A3 (en) 2007-09-13
IL192292A0 (en) 2008-12-29
HK1127995A1 (en) 2009-10-16
JP5452931B2 (ja) 2014-03-26
RU2426552C2 (ru) 2011-08-20
CA2634345C (en) 2016-09-27
PT1962877T (pt) 2020-09-04
NO346419B1 (no) 2022-07-18
JP2009520716A (ja) 2009-05-28
SI1962877T1 (sl) 2020-09-30
CN101340923B (zh) 2013-11-06
US11241470B2 (en) 2022-02-08
AU2006328983A1 (en) 2007-06-28
IL192292A (en) 2013-05-30

Similar Documents

Publication Publication Date Title
ECSP088800A (es) Formulaciones de inhibidores de DPP IV
CR11106A (es) Inhibidores de cinasa p710 s6
GT200600258A (es) Derivados de n-(piridin-2-il)-sulfonamida
BRPI0818672B8 (pt) composições, composições farmacêuticas e usos de 2&#39;flúor-2&#39;-desoxitetra-hidrouridinas
BRPI0510273A (pt) derivados de tetraazabenzo[e]azuleno e análogos destes
ECSP067110A (es) Derivados de 2-carbamida-4-feniltiazol, su preparación y su aplicación en terapéutica
BRPI0608604B8 (pt) moduladores de 2,3-dioxigenase de indolamina e composição farmacêutica
UY30440A1 (es) Nuevos compuestos
DOP2010000387A (es) Compuestos pirazolicos 436
CL2008000197A1 (es) Compuestos derivados de 2,4-diamino pirimidina, inhibidores de antranilamida de cinasa aurora; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer.
NI200800318A (es) Composiciones farmacéuticas estabilizadas que comprenden fesoterodina.
NO20083104L (no) Fast preparat
WO2009008921A3 (en) Influenza b viruses with reduced sensitivity to neuraminidase inhibitors
CL2007003643A1 (es) Composicion farmaceutica de azimilidina que comprende 0,5% a aproximadamente 2,5% (w/w) de agua; y uso para el tratamiento de arritmias cardiacas.
BRPI0909737A2 (pt) compostos de pirrolidinila, composição farmacêutica compreendendo os mesmos e usos dos mesmos
BRPI0620054A8 (pt) extrato obtenível por extração de phaseolus sp. com misturas de etanol e água, processo para a preparação deste, uso e composições dos mesmos
SG152257A1 (en) Topical preparation containing ambroxol
ATE485049T1 (de) Physiologisch aktive zusammensetzung gegen diabetes
MXPA02001343A (es) Derivados de 6-azauracilo que inhiben interleucina-5.
UY30356A1 (es) Derivados de 3-halo-n-(2.(4-fluorofenil)-4-oxobutil)-n-metil-5-(trifluorometil)benzamida y composiciones de los mismos.
BRPI0609765A8 (pt) mistura de isoalcano, método para a preparação da mesma, composição cosmética ou farmacêutica, e, uso de uma mistura de isoalcano
WO2006001961A3 (en) Compositions and methods relating to pyrimidine synthesis inhibitors
BRPI0511999A (pt) compostos como antagonistas de ccr5
ATE485261T1 (de) Salicylsäurederivate
BRPI0514672A (pt) polipeptìdeos de fusobacterium e métodos de uso

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 36/48 (2006.01), A23L 33/105 (2016.01)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL